Advertisement
U.S. markets open in 4 hours 57 minutes
  • S&P Futures

    5,075.25
    -14.75 (-0.29%)
     
  • Dow Futures

    38,920.00
    -96.00 (-0.25%)
     
  • Nasdaq Futures

    17,947.75
    -73.25 (-0.41%)
     
  • Russell 2000 Futures

    2,049.00
    -10.90 (-0.53%)
     
  • Crude Oil

    78.03
    -0.84 (-1.07%)
     
  • Gold

    2,034.50
    -9.60 (-0.47%)
     
  • Silver

    22.49
    -0.27 (-1.20%)
     
  • EUR/USD

    1.0804
    -0.0045 (-0.41%)
     
  • 10-Yr Bond

    4.3150
    0.0000 (0.00%)
     
  • Vix

    13.67
    +0.24 (+1.79%)
     
  • GBP/USD

    1.2634
    -0.0052 (-0.41%)
     
  • USD/JPY

    150.7770
    +0.2970 (+0.20%)
     
  • Bitcoin USD

    59,099.52
    +2,602.49 (+4.61%)
     
  • CMC Crypto 200

    885.54
    0.00 (0.00%)
     
  • FTSE 100

    7,654.13
    -28.89 (-0.38%)
     
  • Nikkei 225

    39,208.03
    -31.49 (-0.08%)
     

Applied Molecular Transport Insider Ups Holding By 239% During Year

Looking at Applied Molecular Transport Inc.'s (NASDAQ:AMTI ) insider transactions over the last year, we can see that insiders were net buyers. That is, there were more number of shares purchased by insiders than there were sold.

Although we don't think shareholders should simply follow insider transactions, logic dictates you should pay some attention to whether insiders are buying or selling shares.

View our latest analysis for Applied Molecular Transport

Applied Molecular Transport Insider Transactions Over The Last Year

Over the last year, we can see that the biggest insider purchase was by Independent Director Aaron VanDevender for US$150k worth of shares, at about US$1.00 per share. That means that an insider was happy to buy shares at above the current price of US$0.17. It's very possible they regret the purchase, but it's more likely they are bullish about the company. To us, it's very important to consider the price insiders pay for shares. It is encouraging to see an insider paid above the current price for shares, as it suggests they saw value, even at higher levels. The only individual insider to buy over the last year was Aaron VanDevender.

You can see the insider transactions (by companies and individuals) over the last year depicted in the chart below. By clicking on the graph below, you can see the precise details of each insider transaction!

insider-trading-volume
insider-trading-volume

Applied Molecular Transport is not the only stock that insiders are buying. For those who like to find winning investments this free list of growing companies with recent insider purchasing, could be just the ticket.

Insiders At Applied Molecular Transport Have Sold Stock Recently

The last quarter saw substantial insider selling of Applied Molecular Transport shares. Specifically, insiders ditched US$104k worth of shares in that time, and we didn't record any purchases whatsoever. In light of this it's hard to argue that all the insiders think that the shares are a bargain.

Does Applied Molecular Transport Boast High Insider Ownership?

Another way to test the alignment between the leaders of a company and other shareholders is to look at how many shares they own. We usually like to see fairly high levels of insider ownership. It appears that Applied Molecular Transport insiders own 26% of the company, worth about US$1.8m. We've certainly seen higher levels of insider ownership elsewhere, but these holdings are enough to suggest alignment between insiders and the other shareholders.

So What Does This Data Suggest About Applied Molecular Transport Insiders?

Insiders sold stock recently, but they haven't been buying. In contrast, they appear keener if you look at the last twelve months. We like that insiders own a fair amount of the company. So the recent selling doesn't worry us too much. So these insider transactions can help us build a thesis about the stock, but it's also worthwhile knowing the risks facing this company. Be aware that Applied Molecular Transport is showing 7 warning signs in our investment analysis, and 4 of those are potentially serious...

But note: Applied Molecular Transport may not be the best stock to buy. So take a peek at this free list of interesting companies with high ROE and low debt.

For the purposes of this article, insiders are those individuals who report their transactions to the relevant regulatory body. We currently account for open market transactions and private dispositions of direct interests only, but not derivative transactions or indirect interests.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Advertisement